Investigation and inquest
On 23 June 2021 I commenced an investigation into the death of
Claire COPELAND
Aged 41.
The investigation concluded at the end of the inquest on 04 March 2022. The conclusion of the inquest was that:
On around 17th June 2021, following a break in the continuity of her treatment for drug addiction, the deceased consumed drugs, including heroin. Claire’s was a drug-related death.
Circumstances of the death
Claire Copeland had a history of heroin use and had received opiate substitution therapy in the months leading to her release from prison on the afternoon of Friday 11th June 2021. She was given that Friday’s dose upon release and it was planned that she would collect further doses on the following Saturday and Sunday from Boots, the Chemist, Consett.
Current procedure involves delivery of a physical prescription document.
Agents of humankind communicated with an employee at Boots to arrange delivery of the necessary prescriptions covering the weekend. A paper version of Claire’s prescription was brought to Consett for delivery that Friday after Boots had closed for the day and Humankind’s agent attempted to effect delivery via a letter box near Boots’ shopfront; that letter box did not belong to Boots so Claire could not obtain her medication for the weekend.
No attempt had been made to confirm effective delivery.
The missing prescription was noted by Boots’ pharmacist when Claire attempted to collect it on the Saturday; at this time Humankind was closed and there was no ready means of obtaining a further prescription.
The agreed system contained no fail-safe provisions ensuring continuity of care in the event of failed delivery of prescription.
Coroner’s concerns
Arrangements to which you are a party:
• rely upon delivery of a physical prescription document;
• allow that delivery be neither witnessed nor confirmed;
• lack effective mechanism immediately to detect failed delivery; and
• lack mechanism to remedy failed delivery; and thereby
presents danger to life in that it is capable of causing discontinuity of important medical treatment.